| Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML) (NCT02203773) | AbbVie | 2014-10-06 |
| Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors (NCT02211755) | National Cancer Institute (NCI) | 2014-10-06 |
| QUILT-3.005: A Study of N-803 in Patients With Relapsed or Refractory Multiple Myeloma (NCT02099539) | Altor BioScience | 2014-10-06 |
| Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers (NCT02257398) | GlaxoSmithKline | 2014-10-06 |
| Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 Diabetes (NCT02265809) | Cambridge University Hospitals NHS Foundation Trust | 2014-10-03 |
| Genetic and Environmental Factors in the Response to Influenza Vaccination (NCT03088904) | Stanford University | 2014-10-03 |
| BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) (NCT02257541) | Memorial Sloan Kettering Cancer Center | 2014-10-02 |
| Acceptability and Efficacy of 'Fish Surimi Peptide' in Under Five Children Suffering From Moderate Acute Malnutrition (NCT02272543) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2014-10-01 |
| Safety and Immunogenicity Study of Na-GST-1 With or Without CpG (NCT02143518) | Baylor College of Medicine | 2014-10-01 |
| Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PKs) of ZYDPLA1 Following Oral Administration in Healthy Volunteers (NCT02620592) | Zydus Lifesciences Limited | 2014-10-01 |
| Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus (NCT02250222) | Ligand Pharmaceuticals | 2014-10-01 |
| Bioequivalence and Adhesion Comparison of Buprenorphine Patches (NCT02268422) | Mundipharma Research Limited | 2014-10-01 |
| Endoscopic Ultrasonography-guided Double Ethanol Lavage for Pancreatic Cysts: a Prospective Cohort Study (NCT02213419) | Samsung Medical Center | 2014-10-01 |
| A Study to Assess the Absolute Bioavailability of Oral Selumetinib in Healthy Male Volunteers. (NCT02238782) | AstraZeneca | 2014-10-01 |
| Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4) (NCT02227459) | Bristol-Myers Squibb | 2014-10-01 |
| The Effect of BI 187004 on the Pharmacokinetics of Cytochrome P450 Substrates (Caffeine, Warfarin, Omeprazole, Metoprolol and Midazolam) and a P Glycoprotein Substrate (Digoxin) (NCT02254148) | Boehringer Ingelheim | 2014-10-01 |
| Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects (NCT02268838) | Eisai Co., Ltd. | 2014-10-01 |
| Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis (NCT02309385) | Aciont Inc | 2014-10-01 |
| A Randomized, Open-label, Single Dose, Parallel Study to Evaluate the Pharmacokinetics Dose Proportionality of GLA5PR GLARS-NF1 Tablet in Healthy Male Volunteers (NCT02327000) | GL Pharm Tech Corporation | 2014-10-01 |
| Study of REGN1193 in Patients With Type 2 Diabetes Mellitus (NCT02284425) | Regeneron Pharmaceuticals | 2014-10-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple s.c Doses HS-20004 in Healthy Chinese Volunteers (NCT02746315) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2014-10-01 |
| DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin (NCT02300363) | Lexicon Pharmaceuticals | 2014-10-01 |
| Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine) (NCT02249221) | Green Cross Corporation | 2014-10-01 |
| Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma (NCT02243189) | Janssen Research & Development, LLC | 2014-10-01 |
| Bioavailability of Omega-3 Food Supplements in Healthy Subjects (NCT02376621) | Pronova BioPharma | 2014-10-01 |
| Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study (NCT02249026) | Gauda, Estelle B., M.D. | 2014-10-01 |
| Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005 (NCT02271412) | Luye Pharma Group Ltd. | 2014-10-01 |
| Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma (NCT02266147) | Dynavax Technologies Corporation | 2014-10-01 |
| A Study of LY3079514 in Healthy Participants (NCT02242903) | Eli Lilly and Company | 2014-10-01 |
| Assessment of the Analgesic Effects of PF-06273340 in Healthy Volunteers Using Evoked Pain Endpoints (NCT02260947) | Pfizer | 2014-10-01 |
| DDI Study With Multiple-dose LX4211 and Single Dose Digoxin (NCT02300350) | Lexicon Pharmaceuticals | 2014-10-01 |
| Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers (NCT02572089) | National Institute on Drug Abuse (NIDA) | 2014-10-01 |
| Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors (NCT02262455) | Santa Maria Biotherapeutics | 2014-10-01 |
| Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone (NCT02235662) | CONRAD | 2014-10-01 |
| Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Method (NCT02276768) | gicare Pharma Inc. | 2014-10-01 |
| Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer (NCT02318901) | Western Regional Medical Center | 2014-10-01 |
| A Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Target Engagement of BMS-986147 in Healthy Subjects (NCT02293629) | Bristol-Myers Squibb | 2014-10-01 |
| MSC Therapy in Liver Transplantation (NCT02260375) | Monia Lorini | 2014-10-01 |
| Caffeine in Amblyopia Study (NCT02594358) | Johns Hopkins University | 2014-10-01 |
| A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 (Dalazatide) in Active Plaque Psoriasis (NCT02435342) | Kineta Inc. | 2014-10-01 |
| A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology (NCT02204345) | Hoffmann-La Roche | 2014-10-01 |
| A Methodology Study to Evaluate a Sitting Knee Measuring Device in Assessing Growth in Indian Children. (NCT02201225) | GlaxoSmithKline | 2014-10-01 |
| Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients (NCT02267733) | Yale University | 2014-10-01 |
| Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA) (NCT02221258) | Kang Stem Biotech Co., Ltd. | 2014-10-01 |
| A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours (NCT02263950) | LondonPharma Ltd. | 2014-10-01 |
| EZCast-DFU Study With Portal for Application of Topical Medications (NCT02131961) | University of Miami | 2014-10-01 |
| Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma (NCT01941849) | University College, London | 2014-10-01 |
| Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR) (NCT02286258) | Assistance Publique - Hôpitaux de Paris | 2014-10-01 |
| Study in Healthy Young Women to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of Vilaprisan (NCT02262663) | Bayer | 2014-10-01 |
| Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells on the Human Response to Lipopolysaccharyde in Human Volunteers (NCT02328612) | Tigenix S.A.U. | 2014-10-01 |
| GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients (NCT02149225) | Immatics Biotechnologies GmbH | 2014-10-01 |
| Intra-operative Infra-red Fluorescent Imaging in Thyroid and Parathyroid Surgery (NCT02089542) | Sheffield Teaching Hospitals NHS Foundation Trust | 2014-10-01 |
| Dose Finding Safety Study of VAL201 in Cancer Patients (NCT02280317) | ValiRx Plc | 2014-10-01 |
| Pharmacokinetic Study of JNJ-42756493 in Healthy Participants (NCT02218073) | Janssen Research & Development, LLC | 2014-10-01 |
| Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma (NCT02282358) | Memorial Sloan Kettering Cancer Center | 2014-10-01 |
| Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers (NCT02647853) | Topokine Therapeutics, Inc. | 2014-10-01 |
| Japanese Bridging Study Conducted in the United States (NCT00947245) | Bristol-Myers Squibb | 2014-10-01 |
| Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL) (NCT02242045) | Gilead Sciences | 2014-10-01 |
| Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer (NCT02240719) | University of California, Davis | 2014-10-01 |
| Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST) (NCT02203968) | Sunnybrook Health Sciences Centre | 2014-10-01 |
| Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia (NCT02274233) | Sideris Pharmaceuticals | 2014-10-01 |
| Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma (NCT02293850) | Oncolys BioPharma Inc | 2014-10-01 |
| Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast (NCT02517372) | RSPR Pharma AB | 2014-10-01 |
| Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease (NCT02183519) | University of Florida | 2014-10-01 |
| Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients After Stroke (NCT01453829) | Ageless Regenerative Institute | 2014-10-01 |
| Safety, Tolerability and PK Study of AK0529 in Healthy Human (NCT02297594) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2014-10-01 |
| Contingency Management, Quitting Smoking, and ADHD (NCT02266784) | Duke University | 2014-10-01 |
| A Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the ROTAHALER® Inhaler Relative to the DISKUS® Inhaler (NCT02218762) | GlaxoSmithKline | 2014-10-01 |
| PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian Participants (NCT02306915) | Merckle GmbH | 2014-10-01 |
| A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination (NCT02362217) | University of Oxford | 2014-10-01 |
| Carfilzomib Plus Belinostat in Relapsed/Refractory NHL (NCT02142530) | Massachusetts General Hospital | 2014-10-01 |
| ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas (NCT02264613) | Aileron Therapeutics, Inc. | 2014-10-01 |
| The Sympara VIBE Study for Hypertension (NCT02250495) | Sympara Medical, Inc. | 2014-10-01 |
| ONO-4538 Phase I Study in Patients With Solid Tumor (NCT02261285) | Ono Pharmaceutical Co., Ltd. | 2014-10-01 |
| Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer (NCT02487823) | Institut Paoli-Calmettes | 2014-10-01 |
| Dichoptic Virtual Reality Therapy for Amblyopia in Adults (NCT02246556) | University of California, San Francisco | 2014-10-01 |
| SSAT061: PK of DTG and EVT/COBI in Healthy Volunteers (NCT02219217) | St Stephens Aids Trust | 2014-10-01 |
| To Evaluate the Cardiac Safety and PK Following a Single Oral Dose Administration of Pacritinib in Healthy Subjects (NCT02807207) | CTI BioPharma | 2014-10-01 |
| Study of Long-Acting Injectable Naltrexone to Treat Cannabis Dependence (NCT02088177) | New York State Psychiatric Institute | 2014-10-01 |
| Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease (NCT04468347) | Avid Radiopharmaceuticals | 2014-10-01 |
| FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 Study (NCT02218775) | Andrew Krystal | 2014-10-01 |
| Diagnostic Aids for Detection and Diagnosis of Oral Cancer (NCT02251639) | M.D. Anderson Cancer Center | 2014-10-01 |
| A Study to Evaluate the Effects of Ibrutinib on Cardiac Repolarization in Healthy Participants (NCT02271438) | Janssen Research & Development, LLC | 2014-10-01 |
| Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer (NCT02125084) | SCRI Development Innovations, LLC | 2014-10-01 |
| A Study to Determine the Safety, Tolerability and Pharmacokinetics of PMZ-2010 (Centhaquin) in Healthy Volunteers (NCT02408731) | Pharmazz, Inc. | 2014-10-01 |
| Bioequivalence Study of Abiraterone Acetate Coated and Uncoated Tablet Formulations in Healthy Male Participants (NCT02230046) | Janssen Research & Development, LLC | 2014-10-01 |
| Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage (NCT02274428) | Samsung Medical Center | 2014-10-01 |
| Phase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AML (NCT02238522) | Zenith Epigenetics | 2014-10-01 |
| Gastrointestinal Integrity After Naproxen + Rebamipide Versus Naproxen + Placebo (NCT02632812) | Biolab Sanus Farmaceutica | 2014-10-01 |
| Thiamin Fortified Fish Sauce as a Means of Combating Infantile Beriberi in Rural Cambodia (NCT02221063) | University of British Columbia | 2014-10-01 |
| An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis (NCT02189252) | AstraZeneca | 2014-10-01 |
| Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers (NCT03542916) | HK inno.N Corporation | 2014-10-01 |
| Safety Study of Combining Ultrasound Microbubbles and Chemotherapy to Treat Malignant Neoplasms of Digestive System (NCT02233205) | Peking University Cancer Hospital & Institute | 2014-10-01 |
| Brief Alcohol Intervention for Adolescents Who Have Attempted Suicide (NCT02426957) | Boston Children's Hospital | 2014-10-01 |
| First-time-in-man, to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BP1.5375 (NCT01965301) | Bioprojet | 2014-10-01 |
| Fecal Microbiota Transplantation in HIV (NCT02256592) | University of California, San Francisco | 2014-10-01 |
| Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects (NCT02271113) | GlycoMimetics Incorporated | 2014-10-01 |
| A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland (NCT02289027) | Centre Hospitalier Universitaire Vaudois | 2014-10-01 |
| Inspired Helium for Ischemic Protection During Knee Replacement Surgery (NCT02012361) | University of Florida | 2014-10-01 |
| Reactogenicity, Safety and Immunogenicity of a LAIV H7N9 Influenza Vaccine (NCT02480101) | Research Institute of Influenza, Russia | 2014-10-01 |